A5058866610- Prostate Cancer Diagnosis and Treatment
- MRI in cancer diagnosis
- Prostate Cancer Treatment and Research
- Radiomics and Machine Learning in Medical Imaging
- Radiology practices and education
- Diversity and Career in Medicine
- Advanced MRI Techniques and Applications
- Urologic and reproductive health conditions
- Urological Disorders and Treatments
- Medical Imaging Techniques and Applications
- Pelvic floor disorders treatments
- Ovarian cancer diagnosis and treatment
- Global Health Workforce Issues
- Urinary and Genital Oncology Studies
- Urinary Bladder and Prostate Research
- Bladder and Urothelial Cancer Treatments
- Radiation Dose and Imaging
- Innovations in Medical Education
- Diverticular Disease and Complications
- Pelvic and Acetabular Injuries
- AI in cancer detection
- Radiopharmaceutical Chemistry and Applications
- Uterine Myomas and Treatments
- Biomedical Text Mining and Ontologies
- Gynecological conditions and treatments
Johns Hopkins University
2016-2025
National Cancer Institute
2020-2025
National Institutes of Health
2007-2025
University College London
2025
Université Claude Bernard Lyon 1
2025
Radboud University Medical Center
2025
Brigham and Women's Hospital
2025
Mount Sinai Hospital
2025
Radboud University Nijmegen
2025
University Medical Center
2025
To evaluate the incremental value of diffusion-weighted (DW) imaging and apparent diffusion coefficient (ADC) mapping in relation to conventional breast magnetic resonance (MR) characterization benign versus malignant lesions at 3.0 T.This retrospective HIPAA-compliant study was approved by institutional review board, with requirement for informed patient consent waived. Of 550 consecutive patients who underwent bilateral MR over a 10-month period, 93 women 101 met following inclusion...
We previously demonstrated the ability to detect metastatic prostate cancer using <i>N</i>-[<i>N</i>-[(<i>S</i>)-1,3-dicarboxypropyl]carbamoyl]-4-<sup>18</sup>F-fluorobenzyl-l-cysteine (<sup>18</sup>F-DCFBC), a low-molecular-weight radiotracer that targets prostate-specific membrane antigen (PSMA). PSMA has been shown be associated with higher Gleason grade and more aggressive disease. An imaging biomarker able clinically significant high-grade primary reliably would address an unmet...
The Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) recommendations standardise the reporting prostate magnetic resonance imaging (MRI) patients on active surveillance (AS) for cancer. An international consensus group recently updated these and identified areas uncertainty.
To determine the incremental benefit of combined endorectal magnetic resonance (MR) imaging and MR spectroscopic imaging, as compared with alone, for sextant localization peripheral zone (PZ) prostate cancer.This prospective multicenter study, conducted by American College Radiology Imaging Network (ACRIN) from February 2004 to June 2005, was institutional review board approved HIPAA compliant. Research associates were required follow consent guidelines Office Human Protection established...
Pathogenesis in Acute Aortic Syndromes: Dissection, Intramural Hematoma, and Penetrating Atherosclerotic UlcerKatarzyna J. Macura1, Frank M. Corl, Elliot K. Fishman David A. BluemkeAudio Available | Share
Abstract Purpose: To investigate the relationship between temporal resolution of dynamic contrast‐enhanced (DCE) magnetic resonance imaging (MRI) and classification breast lesions as benign versus malignant. Materials Methods: Patients underwent T 1 ‐weighted DCE MRI with 15 s/acquisition using 1.5 Tesla (n = 48) 3.0T 33) scanners. Seventy‐nine patients had pathologically proven diagnosis 2 years follow‐up showing no change in lesion size. The was systematically reduced a postprocessing step...
The type of contrast enhancement kinetic curve (i.e., persistently enhancing, plateau, or washout) seen on dynamic contrast-enhanced MRI (DCE-MRI) the breast is predictive malignancy. Qualitative estimates are most commonly used for interpretation DCE-MRI. purpose this study was to compare qualitative and quantitative methods determining DCE-MRI.Ninety-six patients underwent DCE-MRI assessed qualitatively by three radiologists two occasions. For assessment, slope washout calculated. Kappa...
Conventional imaging modalities (CIMs) have limited sensitivity and specificity for detection of metastatic prostate cancer. We examined the potential a first-in-class radiofluorinated small-molecule inhibitor prostate-specific membrane antigen (PSMA), <i>N</i>-[<i>N</i>-[(<i>S</i>)-1,3-dicarboxypropyl]carbamoyl]-4-<sup>18</sup>F-fluorobenzyl-l-cysteine (<sup>18</sup>F-DCFBC), to detect hormone-naïve (HNPC) castration-resistant cancer (CRPC). <b>Methods:</b> Seventeen patients were...